Welcome to our dedicated page for Research Solutions SEC filings (Ticker: RSSS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Research Solutions, Inc. (NASDAQ: RSSS) SEC filings page on Stock Titan provides access to the company’s official regulatory documents as filed with the U.S. Securities and Exchange Commission. These filings offer detailed insight into how Research Solutions reports its financial results, describes its vertical SaaS and AI business, and addresses governance and shareholder matters.
Research Solutions uses current reports on Form 8-K to announce events such as quarterly and annual financial results, preliminary earnings updates, and certain management or governance changes. For example, the company has filed 8-Ks to furnish press releases describing platform and transaction revenue, annual recurring revenue (ARR), gross margin trends, net income, and Adjusted EBITDA, as well as to disclose changes in executive roles.
The company’s proxy statement on Form DEF 14A outlines topics such as director elections, ratification of the independent registered public accounting firm, and advisory votes on executive compensation and the frequency of such votes. It also provides information about the virtual format of the annual meeting, voting procedures, and certain aspects of corporate governance and executive pay.
On this page, users can review Research Solutions’ 10-K and 10-Q filings (when available), which contain more extensive discussions of its vertical SaaS and AI model, revenue sources from platform subscriptions and transactions, risk factors, and segment information. Investors can also examine Form 4 insider transaction reports and other ownership-related filings to understand how officers, directors, and significant shareholders transact in RSSS stock.
Stock Titan enhances these filings with AI-powered summaries that highlight key points, helping readers navigate lengthy documents such as annual reports or complex 8-K disclosures. Real-time updates from EDGAR ensure that new Research Solutions filings appear promptly, while AI explanations can assist users in interpreting financial metrics, non-GAAP measures like Adjusted EBITDA, and governance-related proposals.
Research Solutions CEO Roy W. Olivier reported a Form 4 filing on June 28, 2025, disclosing a transaction dated June 20, 2025. The insider, who serves as both Director and CEO & President, surrendered 2,126 shares of Common Stock at a price of $2.69 per share.
The transaction was coded as 'F', indicating shares were surrendered to cover tax obligations related to vested restricted stock. This surrender was specifically approved by the company's Compensation Committee of the Board of Directors.
Following the reported transaction, Olivier maintains direct beneficial ownership of 608,253 shares of Research Solutions common stock. The transaction demonstrates standard executive compensation tax management practices rather than discretionary trading activity.
Research Solutions CFO William Nurthen reported a Form 4 filing on June 28, 2025, disclosing a transaction that occurred on June 20, 2025. The insider surrendered 2,909 shares of Common Stock at a price of $2.69 per share to cover tax obligations related to vested restricted stock.
Following the transaction, Nurthen continues to hold 380,607 shares directly. The share surrender was specifically approved by the Compensation Committee of the company's Board of Directors as part of standard tax withholding procedures for vested equity compensation.
- Transaction Code: F (Payment of exercise price or tax liability using portion of securities received)
- Ownership Type: Direct
- Role: CFO & Secretary
Research Solutions (RSSS) director Merrill A. McPeak exercised stock options and acquired shares on June 18, 2025. Key transaction details:
- Exercised 75,000 stock options at a strike price of $1.10 per share
- Following the transaction, McPeak directly owns 409,608 shares
- The exercised options were set to expire on June 29, 2025
- The options were originally granted on June 30, 2015 with a 10-year term
This Form 4 filing represents a standard options exercise by an insider before expiration. The transaction timing appears to be driven by the approaching expiration date rather than any specific market outlook. The exercise increases McPeak's direct equity stake in the company, potentially indicating confidence in the company's long-term prospects.